IFLR1000

Walgreens Boots Alliance/KKR $1.4 billion acquisition of PharMerica

2/8/2017
Public acquisition
Select tab

$ 1.4 billion

Announced

2/8/2017

Overview:

  • Walgreens Boots Alliance and KKR have acquired PharMerica for $1.4 billion.
  • Each share of PharMerica will be valued at $29.95.
  • PharMerica provides pharmacy services in the United States.
  • UBS Investment Bank and Bank of America Merrill Lynch have provided financial advice to PharMerica, 

Katrin Kostadinova - Data analyst

Jurisdiction:

United States

Deal type:

Public acquisition

Practice areas:

Private equity
M&A

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences

Firms:
Cleary Gottlieb Steen & Hamilton

Party: Bank of America Merrill Lynch (Financial adviser)

Davis Polk & Wardwell

Party: PharMerica (Target)

Lawyers: Edmond FitzGerald, Louis Goldberg

Simpson Thacher & Bartlett

Party: Kohlberg Kravis Roberts & Co (KKR) (Acquirer)

Lawyers: Adam Shapiro, David Rubinsky, Mark Pflug

Weil Gotshal & Manges

Party: Walgreens Boots Alliance (Acquirer)

Lawyers: Damian Ridealgh, Michael Aiello

Related deals